Rafael Peláez (Rafael Pélaez)

ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 12

Top Topics

Breast Cancer Cells

Histone Deacetylase

Top Venues

Medicinal research reviews

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Miguel Marín, Marta López, Laura Gallego-Yerga, Raquel Álvarez, Rafael Peláez
Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift? Medicinal research reviews (2023)
Laura Gallego-Yerga, Andrea Jazmín Chiliquinga, Rafael Peláez
Novel Tetrazole Derivatives Targeting Tubulin Endowed with Antiproliferative Activity against Glioblastoma Cells. International journal of molecular sciences 24 (13) (2023)
Laura Gallego-Yerga, Valentin Ceña, Rafael Peláez
Potent and Selective Benzothiazole-Based Antimitotics with Improved Water Solubility: Design, Synthesis, and Evaluation as Novel Anticancer Agents. Pharmaceutics 15 (6) (2023)
Miguel Marín, Marta López, Laura Gallego-Yerga, Raquel Álvarez, Rafael Peláez
Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift? Medicinal research reviews 44 (3) (2023)
Sergio Ramos, Alba Vicente-Blázquez, Marta López-Rubio, Laura Gallego-Yerga, Raquel Álvarez, Rafael Peláez
Frentizole, a Nontoxic Immunosuppressive Drug, and Its Analogs Display Antitumor Activity via Tubulin Inhibition. International journal of molecular sciences 24 (24) (2023)
Miguel Marín, Marta López, Laura Gallego-Yerga, Raquel Álvarez, Rafael Peláez
Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift? Medicinal research reviews 44 (3) (2023)
Laura Gallego-Yerga, Valentin Ceña, Rafael Peláez
Potent and Selective Benzothiazole-Based Antimitotics with Improved Water Solubility: Design, Synthesis, and Evaluation as Novel Anticancer Agents. Pharmaceutics 15 (6) (2023)
Sergio Ramos, Alba Vicente-Blázquez, Marta López-Rubio, Laura Gallego-Yerga, Raquel Álvarez, Rafael Peláez
Frentizole, a Nontoxic Immunosuppressive Drug, and Its Analogs Display Antitumor Activity via Tubulin Inhibition. International journal of molecular sciences 24 (24) (2023)
Miguel Marín, Marta López, Laura Gallego-Yerga, Raquel Álvarez, Rafael Peláez
Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift? Medicinal research reviews 44 (3) (2023)
María Ovejero-Sánchez, Gloria Asensio-Juárez, Myriam González, Pilar Puebla, Miguel Vicente-Manzanares, Rafael Peláez, Rogelio González Sarmiento, Ana Belén Herrero
Panobinostat Synergistically Enhances the Cytotoxicity of Microtubule Destabilizing Drugs in Ovarian Cancer Cells. International journal of molecular sciences 23 (21) (2022)
Myriam González, María Ovejero-Sánchez, Alba Vicente-Blázquez, Raquel Álvarez, Ana Belén Herrero, Manuel Medarde, Rogelio González Sarmiento, Rafael Peláez
Microtubule Destabilizing Sulfonamides as an Alternative to Taxane-Based Chemotherapy. International journal of molecular sciences 22 (4) (2021)
Alba Vicente-Blázquez, Myriam González, Raquel Álvarez, Sara Del Mazo, Manuel Medarde, Rafael Peláez
Antitubulin sulfonamides: The successful combination of an established drug class and a multifaceted target. Medicinal research reviews 39 (3) (2018)